Sun Pharma Advanced Research Co P/B Ratio

Current P/B Ratio
4.77
High Valuation
Very High - Significant premium, high growth expectations or speculative

Sun Pharma Advanced Research Co (SPARC) P/B ratio is 4.77 (High), book value per share ₹405.76 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Read Sun Pharma Advanced Research C dividend payments for the complete payout history and dividend yield track record.

Current Valuation Metrics

P/B Ratio 4.77
Current Price ₹193.92
Book Value/Share ₹405.76
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹1,339 Cr
Share Capital ₹33 Cr
Reserves & Surplus ₹1,306 Cr
Outstanding Shares 33,000,000
Book Value per Share ₹405.76

Valuation Signal

Signal Overvalued
Historical Avg 2.52
Historical Range 0.48 - 5.25
Percentile 66.7%

Sector Context

Sector Average -0.01
Sector Median 0.62
Sector Rank #11 of 50
Sector Percentile 22.0%

SPARC P/B Ratio — Valuation Insights & Book Value Analysis

Sun Pharma Advanced Research Co price-to-book ratio interpretation, valuation status and historical context — current P/B 4.77 (High). Explore Sun Pharma Advanced Research C intrinsic price to estimate fundamental worth using multiple valuation models.

  • Stock appears overvalued with PB of 4.77, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 89.0% above historical average
  • Trading at premium to sector average PB of -0.01

Sun Pharma Advanced Research Co P/B Ratio Historical Trend

SPARC annual price-to-book ratio — 3 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see SPARC share price.

SPARC Historical P/B Ratio — Book Value Per Share & Year-End Price

Sun Pharma Advanced Research Co annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 0.48 ₹405.76 ₹193.92 ₹1,339 Low
2024 5.25 ₹38.18 ₹200.55 ₹126 High
2023 1.84 ₹155.45 ₹286.80 ₹513 Moderate

SPARC vs Healthcare Peers — P/B Ratio Comparison

Sun Pharma Advanced Research Co P/B 4.77 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.

Sector Average
-0.01
Sector Median
0.62
Lowest P/B
-6.55
Highest P/B
1.09
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Parmax Pharma PARMAX -6.55 ₹46 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.0 ₹65 Low
Krebs Biochemicals & Ind… KREBSBIO -0.82 ₹129 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.21 ₹50 Low
Triochem Products TRIPR 0.04 ₹0 Low